Center-Authored Papers

Filters: Author is Saracino, Misty  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
Johnston C, Orem J, Okuku F, Kalinaki M, Saracino M, Katongole-Mbidde E, Sande M, Ronald A, McAdam K, Huang M-L et al..  2009.  Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.. PloS one. 4(1):e4222. Abstract
2010
Kask AS, Chen X, Marshak JO, Dong L, Saracino M, Chen D, Jarrahian C, Kendall MA, Koelle DM.  2010.  DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.. Vaccine. 28(47):7483-91. Abstract
Phipps W, Ssewankambo F, Nguyen H, Saracino M, Wald A, Corey L, Orem J, Kambugu A, Casper C.  2010.  Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.. PloS one. 5(11):e13936. Abstract
2011
Sandlin MI, Johnston C, Bowe D, Saracino M, Schacker T, Shaughnessy M, Corey L, Wald A.  2011.  Clinician and Patient Recognition of Anogenital Herpes Disease in HIV Positive Men Who Have Sex With Men.. Sexually transmitted diseases. 38(9):833-6. Abstract
Cattamanchi A, Saracino M, Selke S, Huang M-L, Magaret AS, Celum C, Corey L, Wald A, Casper C.  2011.  Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.. Journal of medical virology. 83(10):1696-703. Abstract
Phipps W, Saracino M, Magaret AS, Selke S, Remington M, Huang M-L, Warren T, Casper C, Corey L, Wald A.  2011.  Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.. The Journal of infectious diseases. 203(2):180-7. Abstract
Strachan E, Saracino M, Selke S, Magaret AS, Buchwald D, Wald A.  2011.  The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women.. Brain, behavior, and immunity. 25(7):1475-81. Abstract
2012
Johnston C, Saracino M, Kuntz S, Magaret AS, Selke S, Huang M-L, Schiffer JT, Koelle DM, Corey L, Wald A.  2012.  Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.. Lancet. 379(9816):641-647. Abstract
Marrazzo JM, Fiedler TL, Srinivasan S, Thomas KK, Liu C, Ko D, Xie H, Saracino M, Fredricks DN.  2012.  Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.. The Journal of infectious diseases. 205(10):1580-8. Abstract
2013
Perti T, Saracino M, Baeten JM, Johnston C, Diem K, Ocbamichael N, Huang M-L, Selke S, Magaret A, Corey L et al..  2013.  High-Dose Valacyclovir Decreases Plasma HIV-1 RNA More Than Standard-Dose Acyclovir in Persons Coinfected with HIV-1 and HSV-2: A Randomized Crossover Trial.. Journal of acquired immune deficiency syndromes (1999). 63(2):201-8. Abstract
2014
Phipps W, Saracino M, Selke S, Huang M-L, Jaoko W, Mandaliya K, Wald A, Casper C, McClelland SR.  2014.  Oral HHV-8 replication among women in Mombasa, Kenya.. Journal of medical virology. Abstract
Administration, Cutaneous
Kask AS, Chen X, Marshak JO, Dong L, Saracino M, Chen D, Jarrahian C, Kendall MA, Koelle DM.  2010.  DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.. Vaccine. 28(47):7483-91. Abstract
Adolescent
Johnston C, Orem J, Okuku F, Kalinaki M, Saracino M, Katongole-Mbidde E, Sande M, Ronald A, McAdam K, Huang M-L et al..  2009.  Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.. PloS one. 4(1):e4222. Abstract
Phipps W, Ssewankambo F, Nguyen H, Saracino M, Wald A, Corey L, Orem J, Kambugu A, Casper C.  2010.  Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.. PloS one. 5(11):e13936. Abstract
Adult
Phipps W, Ssewankambo F, Nguyen H, Saracino M, Wald A, Corey L, Orem J, Kambugu A, Casper C.  2010.  Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.. PloS one. 5(11):e13936. Abstract
Phipps W, Saracino M, Magaret AS, Selke S, Remington M, Huang M-L, Warren T, Casper C, Corey L, Wald A.  2011.  Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.. The Journal of infectious diseases. 203(2):180-7. Abstract
Johnston C, Orem J, Okuku F, Kalinaki M, Saracino M, Katongole-Mbidde E, Sande M, Ronald A, McAdam K, Huang M-L et al..  2009.  Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.. PloS one. 4(1):e4222. Abstract
Aged
Phipps W, Saracino M, Magaret AS, Selke S, Remington M, Huang M-L, Warren T, Casper C, Corey L, Wald A.  2011.  Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.. The Journal of infectious diseases. 203(2):180-7. Abstract
Anal Canal
Phipps W, Saracino M, Magaret AS, Selke S, Remington M, Huang M-L, Warren T, Casper C, Corey L, Wald A.  2011.  Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.. The Journal of infectious diseases. 203(2):180-7. Abstract
Animals
Kask AS, Chen X, Marshak JO, Dong L, Saracino M, Chen D, Jarrahian C, Kendall MA, Koelle DM.  2010.  DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.. Vaccine. 28(47):7483-91. Abstract
Anti-Retroviral Agents
Phipps W, Ssewankambo F, Nguyen H, Saracino M, Wald A, Corey L, Orem J, Kambugu A, Casper C.  2010.  Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.. PloS one. 5(11):e13936. Abstract
Antibodies, Viral
Kask AS, Chen X, Marshak JO, Dong L, Saracino M, Chen D, Jarrahian C, Kendall MA, Koelle DM.  2010.  DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.. Vaccine. 28(47):7483-91. Abstract
Apr 2012
Marrazzo JM, Fiedler TL, Srinivasan S, Thomas KK, Liu C, Ko D, Xie H, Saracino M, Fredricks DN.  2012.  Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.. The Journal of infectious diseases. 205(10):1580-8. Abstract
April 2012
Marrazzo JM, Fiedler TL, Srinivasan S, Thomas KK, Liu C, Ko D, Xie H, Saracino M, Fredricks DN.  2012.  Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.. The Journal of infectious diseases. 205(10):1580-8. Abstract
April 2013
Perti T, Saracino M, Baeten JM, Johnston C, Diem K, Ocbamichael N, Huang M-L, Selke S, Magaret A, Corey L et al..  2013.  High-Dose Valacyclovir Decreases Plasma HIV-1 RNA More Than Standard-Dose Acyclovir in Persons Coinfected with HIV-1 and HSV-2: A Randomized Crossover Trial.. Journal of acquired immune deficiency syndromes (1999). 63(2):201-8. Abstract